← Eichor
Study identifier: NCT06807021 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Post-Operative Use of FS2 to Mitigate Scarring in Burn Patients

Condition: Burn Scar · Burn Wound  ·  Sponsor: Birch BioMed Inc

PhasePhase 2/Phase 3
Planned participants70
Who can joinAll sexes, 12 Years to 65 Years
Healthy volunteersNo

About this study

The goal of this study is to see how an ingredient called kynurenic acid (which we named "FS2") affects scar formation in people with burn injuries that need skin graft surgery. A cream with FS2 will be used on both the area where the skin graft was placed and the area where the skin was taken (donor site). The cream will be applied after the skin has healed. This study will help us understand if FS2 is safe and effective for mitigating skin scar formation in burn patients.

This description comes directly from the study's public registry record.

Talk to the study team

Adam Kuttenkeuler  ·  +1519-341-3367  ·  akuttenkeuler@nutrasource.ca

Stephanie Recker  ·  1-887-557-7722  ·  srecker@nutrasource.ca

Always discuss trial participation with your own doctor first.

Locations (2)

University of Alberta, Division of Plastic SurgeryEdmonton, Alberta, CanadaRecruiting
Centre for Burn Research - Hamilton Health SciencesHamilton, Ontario, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06807021